Digital Handbook: Co-Creating Evidence, Wraparound programs for pregnancy, early parenting & substance use

The Co-Creating Evidence Project (CCE) was a multi-site evaluation of community-based programs that support women in the prevention of FASD through harm reduction oriented, trauma-informed,

Course: Perinatal Substance Use and Collaborative Practice

This course is designed for social workers, case workers, and practice leaders who work with women with substance use concerns and their families in acute

Obstetrics and Gynecology Provider Experience Screening for Harmful Alcohol Use: An Unmet Need for Standardized Screening and Intervention

CanFASD, Why FASD is an essential diagnostic term: Response to the Lancet Article

The Canada FASD Research Network, CanFASD, feels compelled to make an official statementon the recent opinion published in the Lancet by Eliason et al., calling

The Safety of Alcohol Pharmacotherapies in Pregnancy: A Scoping Review of Human and Animal Research

Abstract Background and Objective Alcohol pharmacotherapies pose unknown teratogenic risks in pregnancy and are therefore recommended to be avoided. This limits treatment options for pregnant

Early Alcohol Exposure Leaves Molecular Signature in Fetal Placenta

Retrieved from https://neurosciencenews.com/genetics-alcohol-placenta-27826/ Summary: A recent study shows that alcohol exposure in the earliest stages of pregnancy can lead to detectable molecular changes in the late-gestation

1 3 4 5 6 7 216